M-136

Methotrexate solution

1.0 mg/mL in methanol with 0.1N NaOH, ampule of 1 mL, certified reference material, Cerilliant®

Manufacturer: Supelco

CAS Number: 59-05-2

Select a Size

Pack Size SKU Availability Price
1 ML M-136-1-ML In Stock ₹ 10,068.10

M-136 - 1 ML

₹ 10,068.10

In Stock

Quantity

1

Base Price: ₹ 10,068.10

GST (18%): ₹ 1,812.258

Total Price: ₹ 11,880.358

grade

certified reference material

Quality Level

300

form

liquid

feature

Snap-N-Spike®/Snap-N-Shoot®

packaging

ampule of 1 mL

manufacturer/tradename

Cerilliant®

concentration

1.0 mg/mL in methanol with 0.1N NaOH

technique(s)

gas chromatography (GC): suitableliquid chromatography (LC): suitable

application(s)

pharmaceutical (small molecule)

format

single component solution

Other Options

Image Product Name Manufacturer Price Range
50-164-7348
Indofine Chemical METHOTREXATE, Products for Life Science, 59-05-2, 100 mg
Indofine Chemical ₹ 6,652.75
50-226-0861
Medchemexpress LLC HY-14519 500mg , Methotrexate CAS:59-05-2 Purity:>98%
Medchemexpress LLC ₹ 16,073.40
45-412-6100MG
MilliporeSigma™ Calbiochem™ Methotrexate
MilliporeSigma™ ₹ 12,217.92
NC0929277
Selleck Chemical LLC Methotrexate 100mg 59-05-2 NCI-C04671
Selleck Chemical LLC ₹ 15,699.60
NC1977802
Sigma Aldrich Fine Chemicals Biosciences Methotrexate United States Pharmacopeia (USP) Reference Standard | 59-05-2 | MFCD00064370 | 500MG
Sigma Aldrich Fine Chemicals Biosciences ₹ 47,632.80
NC0472397
Cayman Chemical Methotrexate, 59-05-2, 100 mg
Cayman Chemical ₹ 4,806.00
NC0634286
Selleck Chemical LLC Methotrexate 10mM/1mL 59-05-2 NCI-C04671
Selleck Chemical LLC ₹ 21,039.60
PHR1396
Methotrexate
Supelco ₹ 12,165.60
1414003
Methotrexate
Sigma Aldrich ₹ 41,791.50
M1000000
Methotrexate
Sigma Aldrich ₹ 16,516.80

Related Products

Img

Supelco

IMPC-051-03

1.0 mg/mL in methanol, ampule of 1 ...

Img

Supelco

D-017

100 μg/mL in methanol, ampule of 1 ...

Img

Supelco

D-015

1.0 mg/mL in methanol (as free base...

Img

Supelco

L-025

1.0 mg/mL in methanol (as free base...

Img

Supelco

M-077

1.0 mg/mL in acetonitrile, ampule o...

Img

Supelco

M-078

1.0 mg/mL in acetonitrile, ampule o...

Img

Supelco

C-036

1.0 mg/mL in methanol (as free base...

Description

  • General description: A Certified Spiking Solution® for use in therapeutic drug monitoring (TDM) analyses by HPLC or LC/MS. Used in the treatment of cancer and autoimmune diseases, methotrexate is an antimetabolite and antifolate drug monitored by clinical labs to ensure patients remain within the drug′s therapeutic range. The Snap-N-Spike® format allows laboratories to eliminate weighing operations of hazardous substances such as methotrexate, significantly reducing occupational exposure hazards related to handling of acutely toxic powders, and provides the ability to spike into their matrix of choice just before use.
  • Application: Pharmacokinetic analysis: Methotrexate solution is employed in advanced pharmacokinetic studies using UV-Vis spectrophotometric and colorimetric methods. This application facilitates precise quantification in plasma and tissue, crucial for evaluating drug distribution and effectiveness in cancer treatments (Febrianti et al., 2024).Toxicity and safety monitoring: Observational studies utilize Methotrexate solution to investigate root causes of medication errors and manage toxicity in elderly patients. This research supports safer clinical practices by identifying risk factors and improving patient safety protocols (Bisht et al., 2024).Nephrotoxicity prevention: Research on Methotrexate solution examines hydration strategies to mitigate nephrotoxicity, enhancing therapeutic outcomes. This study is pivotal in optimizing Methotrexate use in clinical settings, ensuring higher safety and efficacy for patients undergoing chemotherapy (Hasanpour et al., 2024).
  • Legal Information: CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

SAFETY INFORMATION

Pictograms

GHS02,GHS06,GHS08,GHS05

Signal Word

Danger

Hazard Statements

H225,H290,H301 + H311 + H331,H370

Precautionary Statements

P210 - P233 - P280 - P301 + P310 - P303 + P361 + P353 - P304 + P340 + P311

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - Met. Corr. 1 - STOT SE 1

Target Organs

Eyes,Central nervous system

WGK

WGK 2

Flash Point(F)

closed cup

Flash Point(C)

closed cup